Aim: Lymph node metastasis in squamous carcinoma of oral cavity carries poor prognosis. Majority of patients in our country present with locally advanced malignancy which has high incidence of micrometastasis. A comprehensive neck dissection in patients with N0 and N1 neck is overkill with resultant morbidity. Lymph node metastasis from oral cavity has predictable pattern. Supraomohyoid neck dissection (SOND) is a one stage treatment and staging procedure in patients with locally advanced oral cancer with N0 and N1 neck.
1
In the western world, the tongue and floor of the mouth are the most common sites of origin for primary squamous cell carcinoma in the oral cavity. However, in India, the buccal mucosa and retromolar trigone are the most frequently encountered primary sites owing to poor oral hygiene in our patients. 2 The presence of lymph node metastasis in squamous carcinoma of oral cavity is the most important prognostic factor. 3 Traditionally, modified radical neck dissection has been done for N1 cases. In this regard, previous studies have shown that the most common sites for metastases of oral tongue cancer were at levels I and II. 4 Buccal mucosa cancers are not aggressive unlike tongue cancers. Clinically positive lymph nodes turns out to be reactive most of the times. The term supraomohyoid neck dissection (SOND) refers to the removal of lymph nodes contained in levels I to III. Usually, SOND has been employed as elective neck dissection for the initial management of neck in patients who have no clinical evidence of lymph node metastasis. The goal of the SOND is to remove the nodes which are at risk while preserving the function and minimizing morbidity. Therefore, we conducted a study to evaluate the oncological outcome after SOND in patients with oral cancers with clinically N1 neck.
MATERIALS AND METHODS
In this retrospective study, we analyzed medical records of 117 patients of oral cavity squamous cell carcinoma with clinically N1 neck between 2007 and 2012. All the patients underwent SOND along with composite resection and reconstruction of defects wherever required after obtaining the written informed consent in RL Jalappa Hospital and Research Centre in Kolar, Karnataka, India (Fig. 1 ). All these patients were operated by the same surgeon to eliminate bias. Patients who had undergone earlier treatment for cancer (surgical or radiotherapy or neoadjuvant chemotherapy) were excluded from the study. The oncological levels of various lymph nodes were marked on the specimen (Fig. 2) . The specimen was evaluated by histopathology and lymph nodes having metastasis and their level was documented. Patients who had T4a tumors or T3 with close margins, deep infiltration, multiple metastatic nodes and extracapsular spread in lymph nodes were administered radiotherapy. Then, the patients were followed up periodically for minimum 2 years.
RESuLTS
A total of 117 patients, who underwent wide excision and supraomohyoid neck dissection for N1 were included. Pathological reports were studied and neck node status was determined. Majority of our patients were females (73.5%) owing to their habit of tobacco chewing. The site in these patients included 93 buccal mucosa, five upper alveolus, five anterior tongue, six lower alveolus, four retromolar trigone, two lips and one floor of mouth (Table 1) . Predominantly, in our series, buccal mucosa cancers followed by the lower alveolus cancers were included. According to AJCC TNM staging system, 48 cases were classified as T2, 58 as T3 and 11 as T4. Among the 117 patients who were clinical N1 cases, 53 (45.3%) were found to have positive nodes on histopathology and 64 (54.7%) were false positive cases ( Table 2 ). Most of the metastasis was found to be in level I lymph node (Table 3) .
Postoperative radiotherapy was given to the neck sites of 65 patients, including those who had pathological N+ nodes, perineural invasion, close surgical margin or advanced primary tumor. Among those patients who had metastasis on histopathology, six had nodal recurrences. The nodal recurrences occurred within a range of 6 to 18 months. Among the nodal recurrence cases, initially during surgery, four patients with clinical N1 had enlarged nodes at level I and two patients had clinical N1 had enlarged nodes at level II. Twelve patients had local recurrence. All the nodal recurrences were within the area of prior SOND site. Five out of six patients who had nodal recurrence had pathological N2b status (level I + II or level II + III). Two patients were salvaged with radical neck dissection. Two of the remaining four patients who were not salvaged with radical neck dissection died due to uncontrolled neck disease, one patient is alive and the other one patient was lost to follow-up. Two out of five patients who were advised postoperative radiotherapy refused. Three patients developed distant metastasis in the lung (Table 4) .
DISCuSSION
Crile first systematically described the radical neck dissection in 1906. 5 Long-term morbidity were associated with ijhns this method. Studies later done showed the predictability of the site of lymph node metastasis. The pattern of lymph node spread in oral cancers described by Lindberg was the rationale for SOND. The highest risk for metastasis was documented in levels I, II and III and metastasis to levels IV and V is extremely low. 4 Study by Shah and his team showed only 9% incidence of positive nodes in level IV. And, the incidence of level V was only 2%. 6 In our group, majority of the patients, 41 had metastasis in level I, four patients had isolated metastasis in level II and 3 had metastasis in level III. Floor of the mouth and tongue had metastasis in level III. As most of our cases involved buccal mucosa metastasis to level III was rare. In our group, 53.7% of clinically N1 were found to be pathologically node negative on histopathology. This could be due to poor oral hygiene with ulcerated growth and super added component of infection resulting in clinically palpable nodes with reactive hyperplasia. This similar pattern was observed in a study done in Taiwan. 7 Though the rate of metastasis to all level increases with N+ disease, the pattern of involvement is similar to N0. A similar study reported 94.3% regional control rates in node positive patients undergoing SOND. 8 Kowalski and their group did not find positive nodes in level IV or V. 9 After mean follow-up of 30 months, 76 patients in our study are alive and disease-free. Six (5.1%) of our patients had neck recurrence. None of our patients had metastasis to level IV. Medina in his study noted a similar failure rate of 12.5% in N+ patients undergoing SOND. 10 Various studies with 20 to 50 patients having N1 disease reported recurrence rates of 4 to 6%. [11] [12] [13] Padedar in his review article has recommended that patients with N+ disease may undergo dissection of levels I, II, III and IV. His review included studies on oropharyngeal lesions. 14 Postoperative radiotherapy was recommended in 65 patients, who had pathological positive nodes, extracapsular spread, perineural invasion, close margins and advanced stage of the disease. Five of the six nodal recurrence cases were advised for postoperative radiotherapy, two of these patients defaulted. The failure rate improved with postoperative radiotherapy. This view is supported by Ambrosch et al in their study.
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CONCLuSION
Supraomohyoid neck dissection is oncologically safe in therapeutic management of cervical lymph nodes. This is true especially for buccal mucosa cancers as they metastasize mostly to levels I and II. The regional control after SOND is comparable to modified radical neck dissection. Supraomohyoid neck dissection when done for cases with N1 neck avoided the morbidity associated with modified radical neck dissection. Addition of postoperative radiotherapy improves the prognosis.
